Anti-PD-L1 Antibody-Cytokine Fusion Protein, IgG (1.14.4)-TNFSF13 (CAT#: ACFP-CQ5089)

This antibody-cytokine fusion protein was achieved by conjugating/fusing the Anti-PD-L1 IgG to TNFSF13. It was expressed in CHO and purified with affinity chromatography. The immunocytokine retains the ability to bind the PD-L1 as well as the biological activity of TNFSF13.

Specific Inquiry
  • Size:
  • Conjugation:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Subcellular Location and Protein Expression
Normal Tissue
RNA Expression

Specifications

  • Target
  • PD-L1
  • Molecule Class
  • IgG-TNFSF13
  • Species Reactivity
  • Human
  • Expression Host
  • CHO
  • Clone
  • 1.14.4
  • Cytokine 1
  • TNFSF13
  • Cytokines 1 Description
  • The protein encoded by this gene is a member of the tumor necrosis factor (TNF) ligand family. This protein is a ligand for TNFRSF17/BCMA, a member of the TNF receptor family. This protein and its receptor are both found to be important for B cell development. In vitro experiments suggested that this protein may be able to induce apoptosis through its interaction with other TNF receptor family proteins such as TNFRSF6/FAS and TNFRSF14/HVEM. Alternative splicing results in multiple transcript variants. Some transcripts that skip the last exon of the upstream gene (TNFSF12) and continue into the second exon of this gene have been identified; such read-through transcripts are contained in GeneID 407977, TNFSF12-TNFSF13.
  • Cytokine 1 Species
  • Human
  • Applications
  • This product can be used therapeutically to deliver biologically active ligands to a desired tissue.

Target

  • Introduction
  • This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation.
  • Alternative Names
  • CD274; PD-L1; PDCD1L1; B7-H; Programmed Death Ligand 1; Programmed Cell Death 1 Ligand 1; PDCD1LG1; B7H1

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Clone 1.14.4"

See other products for "Cd274"

Select a product category from the dropdown menu below to view related products.
Please select product type
Human Antibody Products Mouse Antibody Products Chimeric Antibody Products Humanized Antibody Products IgG Antibody Products Neutralizing Antibody Products Blocking Antibody Products Rabbit Monoclonal Antibody Products Single Domain Antibody Products Fab Antibody Products ScFv Antibody Products ADCC Enhanced Antibody Products Hexamer Antibody Products Non-Human Primate (NHP) Antibody Products Flow Cytometry (FC) related Reagents and Kits: Empowering Cell Function Research ScFv-Fc Chimera Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for ACFP-CQ5089. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare